Sitagliptin/ja: Difference between revisions
Sitagliptin/ja
Created page with "<!-- Definition and medical uses --> '''シタグリプチン'''（'''sitagliptin''', ブランド名'''ジャヌビア'''他）は、2型糖尿病の治療に用いられる抗糖尿病薬である。イギリスではメトホルミンやスルホニルウレアよりも優先度が低いとされている。口から服用する。また、fixed-dos..." Tags: Mobile edit Mobile web edit |
Created page with "{{Oral hypoglycemics/ja}} {{Merck&Co/ja}} {{Portal bar | Medicine}}" |
||
| Line 167: | Line 167: | ||
</div> | </div> | ||
{{Oral hypoglycemics/ja}} | |||
{{Oral hypoglycemics}} | {{Merck&Co/ja}} | ||
{{Merck&Co}} | |||
{{Portal bar | Medicine}} | {{Portal bar | Medicine}} | ||
[[Category:Wikipedia medicine articles ready to translate]] | [[Category:Wikipedia medicine articles ready to translate]] | ||
[[Category:Dipeptidyl peptidase-4 inhibitors]] | [[Category:Dipeptidyl peptidase-4 inhibitors]] | ||
| Line 182: | Line 178: | ||
[[Category:Triazoles]] | [[Category:Triazoles]] | ||
[[Category:Drugs developed by Merck & Co.]] | [[Category:Drugs developed by Merck & Co.]] | ||